iSOFT Expands in Russia after Agreement with ML Park

iSOFTiSOFT Deutschland has strengthened its position in Russia's healthcare market after a partnership agreement with ML Park of Moscow to distribute and support iSOFT's laboratory information systems (LIS). The market in Russia offers huge potential and is set to grow at unprecedented rates. The Russian market for medical technology is worth US$2 billion a year and is growing by about 15 per cent per annum. The 'National Health Programme', which was initiated by president Putin (until 2010) provides US$1.7 billion to build 15 specialised health centres.

iSOFT has already installed its LabCentre laboratory system at KDL Test, a private laboratory chain with laboratories in Moscow, Omsk, Perm and Krasnodar. ML Park and KDL Test are sister companies and both are subsidiaries of ML Group.

iSOFT Deutschland, part of the IBA Health Group – the world's fourth largest healthcare IT provider – will focus on providing modern laboratory software solutions in Russia. Peter Herrmann, Managing Director, iSOFT Deutschland, said: "Through our partnership with ML Park we can support our Russian laboratory customers locally and develop systems to meet local needs. An early presence in this booming healthcare market is absolutely necessary. For us, this will be the basis for more efficient market cultivation and a fast and wide market penetration with our solutions.

ML Park's knowledge of laboratory systems and the private LIS market in Russia will be invaluable in establishing a support organisation in Russia."

Core elements of the agreement are the distribution, implementation and support of the leading iSOFT laboratory solution, LabCentre. iSOFT is the market leader in laboratory information systems with more than 270 installations in Germany, Switzerland, Austria, Russia and Malaysia. LabCentre is a full-graphic integrated system, covering clinical laboratory, blood donation and microbiology.

Related news articles:

About iSOFT
Following a merger completed on Tuesday 30 October, iSOFT is now part of the IBA Health Group. For further information, please visit http://www.ibahealth.com.

iSOFT products are used by more than 8,000 organisations in 27 countries for managing patient information and driving improvements in healthcare services. For further information, please visit http://www.isoftplc.com.

Most Popular Now

AI-Powered CRISPR could Lead to Faster G…

Stanford Medicine researchers have developed an artificial intelligence (AI) tool to help scientists better plan gene-editing experiments. The technology, CRISPR-GPT, acts as a gene-editing “copilot” supported by AI to help...

Groundbreaking AI Aims to Speed Lifesavi…

To solve a problem, we have to see it clearly. Whether it’s an infection by a novel virus or memory-stealing plaques forming in the brains of Alzheimer’s patients, visualizing disease processes...

AI Spots Hidden Signs of Depression in S…

Depression is one of the most common mental health challenges, but its early signs are often overlooked. It is often linked to reduced facial expressivity. However, whether mild depression or...

ChatGPT 4o Therapeutic Chatbot 'Ama…

One of the first randomized controlled trials assessing the effectiveness of a large language model (LLM) chatbot 'Amanda' for relationship support shows that a single session of chatbot therapy...

AI Tools Help Predict Severe Asthma Risk…

Mayo Clinic researchers have developed artificial intelligence (AI) tools that help identify which children with asthma face the highest risk of serious asthma exacerbation and acute respiratory infections. The study...

AI Model Forecasts Disease Risk Decades …

Imagine a future where your medical history could help predict what health conditions you might face in the next two decades. Researchers have developed a generative AI model that uses...

AI Model Indicates Four out of Ten Breas…

A project at Lund University in Sweden has trained an AI model to identify breast cancer patients who could be spared from axillary surgery. The model analyses previously unutilised information...

AI Distinguishes Glioblastoma from Look-…

A Harvard Medical School–led research team has developed an AI tool that can reliably tell apart two look-alike cancers found in the brain but with different origins, behaviors, and treatments. The...

Smart Device Uses AI and Bioelectronics …

As a wound heals, it goes through several stages: clotting to stop bleeding, immune system response, scabbing, and scarring. A wearable device called "a-Heal," designed by engineers at the University...

Overcoming the AI Applicability Crisis a…

Opinion Article by Harry Lykostratis, Chief Executive, Open Medical. The government’s 10 Year Health Plan makes a lot of the potential of AI-software to support clinical decision making, improve productivity, and...

Dartford and Gravesham Implements Clinis…

Dartford and Gravesham NHS Trust has taken a significant step towards a more digital future by rolling out electronic test ordering using Clinisys ICE. The trust deployed the order communications...